AVON, Mass., Oct. 2, 2023 /PRNewswire/ -- Ranfac Corp., an established medical device manufacturer of Class I and II single-use medical devices is announcing the complete acquisition and ownership of Cervos Medical, LLC.

2023年10月2日，马萨诸塞州雅芳市/PRNewswire/-Ranfac Corp.是一家成熟的I类和II类一次性医疗器械制造商，宣布完全收购和拥有Cervos medical，LLC。

Continue Reading

继续阅读

Cervos will build upon their solid foundation in the orthobiologic industry with expanded access to Ranfac's resourses..

Cervos将在orthobiologic行业奠定坚实的基础，扩大对Ranfac资源的访问范围。。

Tweet this

推特这个

Cervos Medical, LLC Logo

Cervos Medical，LLC徽标

Cervos Medical, originally established as a joint venture between Ranfac Corp. and EndoCellutions Inc. in 2021, is focused on the development and commercialization of proprietary technologies for the harvesting and processing of autologous tissues, including patented technologies for Bone Marrow Aspiration, Platelet Rich Plasma, and Adipose Tissue Processing among other complimentary tools and devices..

Cervos Medical最初成立于2021年，由Ranfac Corp.和EndoCellutions Inc.合资，致力于开发和商业化专有技术，用于采集和加工自体组织，包括骨髓穿刺专利技术，富含血小板血浆，和脂肪组织处理以及其他免费工具和设备。。

Harlan Adler, President of Ranfac Corp., expressed his enthusiasm for this achievement, which marks the company's first acquisition in its 135 year history.  'We are in the infancy of utilizing patients' own tissues to advance natural healing.  Ranfac, with the addition of Cervos Medical, looks forward to working alongside our community of physicians, commercial partners and all other stakeholders to lead innovation for and accelerate the adoption of these important technologies for years to come.'.

Ranfac公司总裁Harlan Adler对这一成就表示了热情，这标志着该公司135年来的首次收购。“我们正处于利用患者自身组织促进自然愈合的初期阶段。随着Cervos Medical的加入，Ranfac期待与我们的医生，商业合作伙伴和所有其他利益相关者共同努力，领导创新并加速未来几年采用这些重要技术。

Operating as a fully owned subsidiary of Ranfac Corp, Cervos Medical will build upon their solid foundation in the orthobiologic industry with expanded access to Ranfac Corp resources, expertise, network, and ability to scale operations to meet emerging opportunity and demand.  Andrew McGillicuddy, who previously served as CEO of Endocelltuions, Inc., will join Ranfac Corp to continue heading innovation efforts as a key leader of Cervos Medical.For additional information regarding Ranfac Corp and its comprehensive range of medical devices, please visit www.ranfac.com.

Cervos Medical作为Ranfac Corp的国有子公司运营，将建立在其在orthobiologic行业的坚实基础之上，扩大对Ranfac Corp资源，专业知识，网络的访问范围，以及扩大运营规模以满足新兴机会和需求的能力。之前担任Endocelltuions，Inc。首席执行官的Andrew McGillicuddy将加入Ranfac Corp，继续领导创新工作，担任Cervos Medical的主要领导者。有关Ranfac Corp及其全面医疗器械的更多信息，请访问www.Ranfac.com。

To explore Cervos Medical's groundbreaking work in cell-based therapies, visit their website at www.cervos.com.About Ranfac Corp:Ranfac Corp., an ISO 13485:2016 medical device company founded in 1888, offers a highly automated and scalable platform dedicated to the manufacturing of Class I and II medical devices.  Working with medical device companies of all sizes, Ranfac Corp offers comprehensive capabilities throughout every production stage within their Avon, Massachusetts facility and offers a range of Ranfac labeled devices across multiples therapeutic categories.About Cervos Medical, LLC:Cervos Medical, LLC., founded in early 2021, is a procedure driven medical device company focused on innovative solutions to improve natural recovery.

为了探索Cervos Medical在基于细胞疗法方面的开创性工作，请访问他们的网站www.Cervos.com.About-Ranfac Corp:Ranfac Corp.，一家成立于1888年的ISO 13485:2016医疗器械公司，提供高度自动化和可扩展的平台致力于制造I类和II类医疗器械。与各种规模的医疗器械公司合作，Ranfac公司在其马萨诸塞州雅芳工厂的每个生产阶段提供全面的功能，并提供多种治疗类别的一系列Ranfac标记设备。关于Cervos Medical，LLC:Cervos Medical，LLC成立于2021年初，是一家以程序驱动的医疗器械公司，专注于改善自然恢复的创新解决方案。

Their best-in-class autologous orthobiologic products mimic and promote vasculogenesis, the body's natural reparative mechanism.  They develop minimally invasive, highly efficient, and cost-effective solutions across a range of specialties.SOURCE Ranfac.

他们一流的自体orthobiologic产品模仿和促进血管生成，身体的自然修复机制。他们在各种专业领域开发微创，高效和经济高效的解决方案。来源Ranfac。